Compare Robinhood Markets, Inc. (HOOD) vs Regeneron Pharmaceuticals Inc (REGN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Robinhood Markets, Inc. vs Regeneron Pharmaceuticals Inc — how do they compare? Robinhood Markets, Inc. trades at $95.26 (market cap $84.86B), while Regeneron Pharmaceuticals Inc trades at $796.38 (market cap $82.06B). The key difference: Robinhood Markets, Inc. and Regeneron Pharmaceuticals Inc are close in size by market cap, and Regeneron Pharmaceuticals Inc pays a 0.47% dividend while Robinhood Markets, Inc. pays none. Which is the better fit depends on your goals.
| HOOD | REGN | |
|---|---|---|
Market Cap | $84.86B | $82.06B |
Sector | Technology | Health |
52-Week High | $152.46 | $812.27 |
52-Week Low | $65.16 | $555.51 |
Enterprise Value | $91.40B | $76.77B |
Dividend Yield | — | 0.47% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Robinhood Markets, Inc.
Robinhood Markets, Inc. operates a financial services platform. The Company offers brokerage and cash management applications such as stocks, exchange-traded funds, options, and cryptocurrency. Robinhood Markets serves clients in the United States.
Read more on HOOD →About Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases
Read more on REGN →
